VeeMed and Voyce Partnership Brings Real-Time Language Interpretation to Telehealth Visits

VeeMed’s built-in telehealth platform now incorporates Voyce interpreters speaking more than 235 languages

VeeMed, a provider of a Virtual Care as-a-Service (VCaaS) for the full continuum of healthcare, and Voyce, a technology company that provides Video Remote Interpretation (VRI), today announced that Voyce medically-trained interpreters will now be available for doctor-to-patient video calls made on the VeeMed telehealth platform.

Typically, telehealth users have to dial into a call center and wait until an interpreter can be found, but this partnership eliminates that step.  Veemed users can now access live, on-demand language interpreters, often in less than 20 seconds, with the integration of the Voyce technology into the care session.

“With one in five Americans speaking a language other than English, the need for reliable, accessible interpretation is growing,” said Voyce CEO, Andrew Royce. According to Census Bureau data from 2018, more than 20% of U.S. residents spoke a language other than English at home. “This partnership allows a remotely-accessed, live interpreter to see and hear critical information from both physician and patient within VeeMed’s telehealth platform that will ultimately lead to diagnosis and care, regardless of language spoken. HIPAA-compliant communication across a variety of languages helps ensure quality healthcare services.”

VeeMed’s leading virtual care technology, applied analytics and proven VCaaS platform integrate with Voyce to eliminate the need to wait for interpreters, saving healthcare facilities and doctors time and money.

“Fast, real-time, remote communication between physicians and patients is the true promise of telehealth, and having interpreters available on demand simply extends that promise,” said Ijaz Arif, chairman and CEO of VeeMed. “We live in a multilingual world, and this partnership with Voyce extends the usefulness of our telehealth platform to a vastly larger patient base.”